Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective adalimumab study in rheumatoid arthritis
ISRCTN68762628Phase 4Completed
- Sponsor
- Academic Medical Center
- Start
- Apr 2004
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in rheumatoid arthritis (RA), sponsored by Academic Medical Center. Primary endpoints: Clinical efficacy at week 16 by EULAR response criteria and Markers distinguishing responders from non-responders. Started Apr 2004; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ISRCTN68762628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN68762628.